1. Hino, A, Adachi, H, Toyomasu, K, et al. (2004) Very long chain n-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 176, 145–149.
2. Calder, PC & Yaqoob, P (2009) Omega-3 long chain polyunsaturated fatty acids and human health outcomes. Biofactors 35, 266–272.
3. Meyer, BJ, Onyiaodike, CC, Brown, EA, et al. (2016) Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy. J Clin Endocrinol Metab 101, 1745–1753.
4. Makrides, M & Gibson, RA (2000) Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr 71, 307S–311S.
5. GISSI Prevezione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
6. Yokoyama, M, Origasa, H, Matsuzaki, M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
7. Sinn, N, Milte, C & Howe, PR (2010) Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients 2, 128–170.
8. Parletta, N, Milte, CM & Meyer, BJ (2013) Nutritional modulation of cognitive function and mental health. J Nutr Biochem 24, 725–743.
9. Duvall, MG & Levy, BD (2016) DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 785, 144–155.
10. Harris, WS, Pottala, JV, Lacey, SM, et al. (2012) Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 225, 425–431.
11. Sala-Vila, A, Harris, WS, Cofán, M, et al. (2011) Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br J Nutr 106, 425–431.
12. Sullivan, BL, Williams, PG & Meyer, BJ (2006) Biomarker validation of a long-chain omega-3 polyunsaturated fatty acid food frequency questionnaire. Lipids 41, 845–850.
13. Lands, WE (1992) Biochemistry and physiology of n-3 fatty acids. FASEB 6, 2530–2536.
14. Meyer, BJ (2011) Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? Prostaglandins Leukot Essent Fatty Acids 85, 275–280.
15. Harris, WS & Von Schacky, C (2004) The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
16. Stark, KD, Aristizabal Henao, JJ, Metherel, AH, et al. (2016) Translating plasma and whole blood fatty acid compositional data into the sum of eicosapentaenoic and docosahexaenoic acid in erythrocytes. Prostaglandins Leukot Essent Fatty Acids 104, 1–10.
18. Effective Public Health Practice Project (1998) Quality Assessment Tool For Quantitative Studies. Hamilton, ON: Effective Public Health Practice Project. https://merst.ca/ephpp/ (accessed June 2017).
19. Lohner, S, Fekete, K, Marosvölgyi, T, et al. (2013) Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab 62, 98–112.
20. Ulven, SM & Holven, KB (2015) Comparison of bioavailability of krill oil versus fish oil and health effect. Vasc Health Risk Manag 11, 511–524.
21. Baker, EJ, Miles, EA, Burdge, GC, et al. (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res 64, 30–56.
22. Schuchardt, JP & Hahn, A (2013) Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 89, 1–8.
23. Harris, WS, Pottala, JV, Varvel, SA, et al. (2013) Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88, 257–263.
24. Al-Hilal, M, Alsaleh, A, Maniou, Z, et al. (2013) Genetic variation at the FADS1–FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement. J Lipid Res 54, 542–551.
25. Mathias, RA, Vergara, C, Gao, L, et al. (2010) FADS genetic variants and omega-6 polyunsaturated fatty acid metabolism in a homogeneous island population. J Lipid Res 51, 2766–2774.
26. Gillingham, LG, Harding, SV, Rideout, TC, et al. (2013) Dietary oils and FADS1–FADS2 genetic variants modulate [13C]alpha-linolenic acid metabolism and plasma fatty acid composition. Am J Clin Nutr 97, 195–207.
27. Tintle, NL, Pottala, JV, Lacey, S, et al. (2015) A genome–wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study. Prostaglandins Leukot Essent Fatty Acids 94, 65–72.
28. Malerba, G, Schaeffer, L, Xumerle, L, et al. (2008) SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 43, 289–299.
29. Schaeffer, L, Gohlke, H, Muller, M, et al. (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15, 1745–1756.
30. Rzehak, P, Heinrich, J, Klopp, N, et al. (2009) Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 101, 20–26.
31. Tanaka, T, Shen, J, Abecasis, GR, et al. (2009) Genome–wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 5, e1000338.
32. Baylin, A, Ruiz-Naraez, E, Kraft, P, et al. (2007) Alpha-linolenic acid, delta 6 desaturase gene polymorphism, and the risk of myocardial infarction. Am J Clin Nutr 85, 554–560.
33. Alsaleh, A, Maniou, Z, Lewis, F, et al. (2014) ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement. Genes Nutr 9, 362.
34. Plourde, M, Vohl, MC, Vandal, M, et al. (2009) Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men. Br J Nutr 102, 1121–1124.
35. Chouinard-Watkins, R, Rioux-Perreault, C, Fortier, M, et al. (2013) Disturbance in uniformly C-13-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon 4 allele. Br J Nutr 110, 1751–1759.
36. Yassine, HN, Rawat, V, Mack, WJ, et al. (2016) The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease. Alzheimers Res Ther 8, 25–25.
37. Whalley, L, Deary, I, Starr, J, et al. (2008)
n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 87, 449–454.
38. Samieri, C, Feart, C, Proust-Lima, C, et al. (2011) Omega-3 fatty acids and cognitive decline: modulation by ApoE epsilon 4 allele and depression. Neurobiol Aging 32, 2317.e13–2317.e22.
39. Walker, CG, Browning, LM, Mander, AP, et al. (2014) Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans. Br J Nutr 111, 679–689.
40. Fortier, M, Tremblay-Mercier, J, Plourde, M, et al. (2010) Higher plasma n-3 fatty acid status in the moderately healthy elderly in southern Quebec: higher fish intake or aging-related change in n-3 fatty acid metabolism? Prostaglandins Leukot Essent Fatty Acids 82, 277–280.
41. Rees, D, Miles, E, Banerjee, T, et al. (2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 83, 331–342.
42. Vandal, M, Freemantle, E, Tremblay-Mercier, J, et al. (2008) Plasma omega-3 fatty acid response to a fish oil supplement in the healthy elderly. Lipids 43, 1085–1089.
43. Plourde, M, Chouinard-Watkins, R, Vandal, M, et al. (2011) Plasma incorporation, apparent retroconversion and [beta]-oxidation of 13C-docosahexaenoic acid in the elderly. J Nutr Metab 8, 5.
44. Hennebelle, M, Courchesne-Loyer, A, St-Pierre, V, et al. (2016) Preliminary evaluation of a differential effect of an [alpha]-linolenate-rich supplement on ketogenesis and plasma [omega]-3 fatty acids in young and older adults. Nutrition 32, 1211–1216.
45. Bjerve, KS, Fougner, KJ, Midthjell, K, et al. (1989)
n-3 fatty-acids in old-age. J Intern Med 225, 191–196.
46. Kuriki, K, Nagaya, T, Imaeda, N, et al. (2002) Discrepancies in dietary intakes and plasma concentrations of fatty acids according to age among Japanese female dietitians. Eur J Clin Nutr 56, 524–531.
47. Ogura, T, Takada, H, Okuno, M, et al. (2010) Fatty acid composition of plasma, erythrocytes and adipose: their correlations and effects of age and sex. Lipids 45, 137–144.
48. Otsuka, R, Kato, Y, Imai, T, et al. (2013) Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79. Lipids 48, 719–727.
49. Sands, SA, Reid, KJ, Windsor, SL, et al. (2005) The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 40, 343–347.
50. de Groot, RH, van Boxtel, MP, Schiepers, OJ, et al. (2009) Age dependence of plasma phospholipid fatty acid levels: potential role of linoleic acid in the age-associated increase in docosahexaenoic acid and eicosapentaenoic acid concentrations. Br J Nutr 102, 1058–1064.
51. Bolton-Smith, C, Woodward, M & Tavendale, R (1997) Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur J Clin Nutr 51, 619–624.
52. Block, RC, Harris, WS & Pottala, JV (2008) Determinants of blood cell omega-3 fatty acid content. Open Biomark J 1, 1–6.
53. Kawabata, T, Hirota, S, Hirayama, T, et al. (2011) Age-related changes of dietary intake and blood eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels in Japanese men and women. Prostaglandins Leukot Essent Fatty Acids 84, 131–137.
54. Sfar, S, Laporte, F, Braham, H, et al. (2010) Influence of dietary habits, age and gender on plasma fatty acids levels in a population of healthy Tunisian subjects. Exp Gerontol 45, 719–725.
55. Crowe, FL, Skeaff, CM, Green, TJ, et al. (2008) Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 99, 168–174.
56. Saga, LC, Liland, KH, Leistad, RB, et al. (2012) Relating fatty acid composition in human fingertip blood to age, gender, nationality and n-3 supplementation in the Scandinavian population. Int J Food Sci Nutr 63, 790–795.
57. Babin, F, Abderrazik, M, Favier, F, et al. (1999) Differences between polyunsaturated fatty acid status of non-institutionalised elderly women and younger controls: a bioconversion defect can be suspected. Eur J Clin Nutr 53, 591–596.
58. Dewailly, E, Blanchet, C, Lemieux, S, et al. (2002) Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 76, 85–92.
59. Dewailly, E, Blanchet, C, Gingras, S, et al. (2001) Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74, 603–611.
60. Itomura, M, Fujioka, S, Hamazaki, K, et al. (2008) Factors influencing EPA plus DHA levels in red blood cells in Japan. In vivo 22, 131–135.
61. Dewailly, E, Blanchet, C, Lemieux, S, et al. (2001)
n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74, 464–473.
62. Tavendale, R, Lee, AJ, Smith, WC, et al. (1992) Adipose tissue fatty acids in Scottish men and women: results from the Scottish Heart Health Study. Atherosclerosis 94, 161–169.
63. Kuriki, K, Nagaya, T, Tokudome, Y, et al. (2003) Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133, 3643–3650.
64. Cazzola, R, Rondanelli, M, Russo-Volpe, S, et al. (2004) Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 45, 1846–1851.
65. Makhoul, Z, Kristal, AR, Gulati, R, et al. (2011) Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr 65, 808–817.
66. Micallef, M, Munro, I, Phang, M, et al. (2009) Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102, 1370–1374.
67. Howe, PR, Buckley, JD, Murphy, KJ, et al. (2014) Relationship between erythrocyte omega-3 content and obesity is gender dependent. Nutrients 6, 1850–1860.
68. Nikolaidis, M & Mougios, V (2004) Effects of exercise on the fatty-acid composition of blood and tissue lipids. Sports Med 34, 1051–1076.
69. Sumikawa, K, Mu, Z, Inoue, T, et al. (1993) Changes in erythrocyte membrane phospholipid composition induced by physical training and physical exercise. Eur J Appl Physiol 67, 132–137.
70. Andersson, A, Sjodin, A, Hedman, A, et al. (2000) Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men. Am J Physiol Endocrinol Metab 279, E744–E751.
71. Kamada, T, Tokuda, S, Aozaki, S, et al. (1993) Higher levels of erythrocyte membrane fluidity in sprinters and long-distance runners. J Appl Physiol 74, 354–358.
72. Arsic, A, Vucic, V, Tepsic, J, et al. (2012) Altered plasma and erythrocyte phospholipid fatty acid profile in elite female water polo and football players. Appl Physiol Nutr Metab 37, 40–47.
73. Tepsic, J, Vucic, V, Arsic, A, et al. (2009) Plasma and erythrocyte phospholipid fatty acid profile in professional basketball and football players. Eur J Appl Physiol 107, 359–365.
74. de Lorgeril, M, Salen, P, Martin, J-L, et al. (2008) Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking. Am Heart J 155, 175–181.
75. di Giuseppe, R, de Lorgeril, M, Salen, P, et al. (2009) Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. Am J Clin Nutr 89, 354–362.
76. Theret, N, Bard, JM, Nuttens, MC, et al. (1993) The relationship between the phospholipid fatty acid composition of red blood cells, plasma lipids, and apolipoproteins. Metabolism 42, 562–568.
77. Simon, JA, Fong, J, Bernert, J, et al. (1996) Relation of smoking and alcohol consumption to serum fatty acids. Am J Epidemiol 144, 325–334.
78. Perret, B, Ruidavets, JB, Vieu, C, et al. (2002) Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol Clin Exp Res 26, 1134–1140.
79. Simonetti, P, Brusamolino, A, Pellegrini, N, et al. (1995) Evaluation of the effect of alcohol consumption on erythrocyte lipids and vitamins in a healthy population. Alcohol Clin Exp Res 19, 517–522.
80. Alling, C, Gustavsson, L, Kristensson-Aas, A, et al. (1984) Changes in fatty acid composition of major glycerophospholipids in erythrocyte membranes from chronic alcoholics during withdrawal. Scand J Clin Lab Invest 44, 283–289.
82. Leng, GC, Smith, FB, Fowkes, FGR, et al. (1994) Relationship between plasma essential fatty-acids and smoking, serum-lipids, blood-pressure and hemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 51, 101–108.
83. Hibbeln, JR, Makino, KK, Martin, CE, et al. (2003) Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 53, 431–441.
84. West, AL, Burdge, GC & Calder, PC (2016) Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial. Br J Nutr 116, 788–797.
85. Lawson, LD & Hughes, BG (1988) Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun 156, 960–963.
86. Garaiova, I, Guschina, IA, Plummer, SF, et al. (2007) A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J 6, 4.
87. Yurko-Mauro, K, Kralovec, J, Bailey-Hall, E, et al. (2015) Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids Health Dis 14, 99.
88. Ramprasath, V, Eyal, I, Zchut, S, et al. (2015) Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Lipids Health Dis 14, 142.
89. Bakewell, L, Burdge, GC & Calder, PC (2006) Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 96, 93–99.
90. Childs, C, Kew, S, Finnegan, Y, et al. (2014) Increased dietary alpha-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study. Nutr J 13, 113.
91. Burdge, GC, Jones, AE & Wootton, SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 88, 355–363.
92. Burdge, GC & Wootton, SA (2002) Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88, 411–420.
93. Emken, EA, Adlof, RO & Gulley, RM (1994) Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1213, 277–288.
94. Childs, CE, Romeu-Nadal, M, Burdge, GC, et al. (2008) Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 67, 19–27.
95. Stewart, F, Rodie, VA, Ramsay, JE, et al. (2007) Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids 42, 335–344.
96. Lemaitre, RN, Tanaka, T, Tang, W, et al. (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome–wide association studies from the CHARGE Consortium. Plos Genetics 7, e1002193–e1002193.
97. Olusi, SO (2002) Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes 26, 1159–1164.
98. Vasilaki, AT & McMilan, DC (2011) Lipid peroxidation. In
Encyclopedia of Cancer [M Schwab, editor]. Berlin, Heidelberg: Springer.
99. Flock, M, Skulas-Ray, A, Harris, W, et al. (2013) Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose–response randomized controlled trial. J Am Heart Assoc 2, e000513.
100. Horowitz, JF & Klein, S (2000) Lipid metabolism during endurance exercise. Am J Clin Nutr 72, 558S–563S.
101. von Schacky, C, Kemper, M, Haslbauer, R, et al. (2014) Low omega-3 index in 106 German elite winter endurance athletes: a pilot study. Int J Sport Nutr Exerc Metab 24, 559–564.
102. Andersson, A, Sjodin, A, Olsson, R, et al. (1998) Effects of physical exercise on phospholipid fatty acid composition in skeletal muscle. Am J Physiol 274, E432–E438.
103. Pawlosky, RJ, Bacher, J & Salen, N (2001) Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low n-3 fatty acid diet. Alcohol Clin Exp Res 25, 1758–1765.
104. Pawlosky, RJ, Flynn, BM & Salem, NJ (1997) The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in rhesus monkeys. Hepatology 26, 1386–1392.
105. Narce, M, Poisson, JP, Bellenger, J, et al. (2001) Effect of ethanol on polyunsaturated fatty acid biosynthesis in hepatocytes from spontaneously hypertensive rats. Alcohol Clin Exp Res 25, 1231–1237.
106. Pawlosky, RJ & Salem, N Jr (2004) Perspectives on alcohol consumption: liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 34, 27–33.
107. Christensen, JH, Skou, HA, Fog, L, et al. (2001) Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103, 651–657.
108. Thompson, RL, Pyke, SDM, Scott, EA, et al. (1993) Cigarette smoking, polyunsaturated fats, and coronary heart disease. Ann N Y Acad Sci 686, 130–138.
109. Thompson, RL, Pyke, SDM, Scott, EA, et al. (1995) Dietary change after smoking cessation: a prospective study. Br J Nutr 74, 27–38.
110. D’Avanzo, B, La Vecchia, C, Braga, C, et al. (1997) Nutrient intake according to education, smoking, and alcohol in Italian women. Nutr Cancer 28, 46–51.
111. Pryor, W (1997) Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105, 875–882.
112. Lowe, ME (1997) Molecular mechanisms of rat and human pancreatic triglyceride lipases. J Nutr 127, 549–557.
113. Franco, RS (2012) Measurement of red cell lifespan and aging. Transfus Med Hemother 39, 302–307.
118. Makela, P, Gmel, G, Grittner, U, et al. (2006) Drinking patterns and their gender differences in europe. Alcohol Alcohol 41, i8–i18.
119. Australian Institute of Health and Welfare (2010) Drinking Patterns in Australia, 2001–2007. Canberra: AIHW; Cat. no. PHE 133.
122. Stark, KD, Van Elswyk, ME, Higgins, MR, et al. (2016) Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 63, 132–152.
123. McGorry, PD, Nelson, B, Markulev, C, et al. (2017) Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial. JAMA Psychiatry 74, 19–27.
124. Murphy, KJ, Meyer, BJ, Mori, TA, et al. (2007) Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr 97, 749–757.
125. Meyer, BJ & Groot, RHM (2017) Effects of omega-3 long chain polyunsaturated fatty acid supplementation on cardiovascular mortality: the importance of the dose of DHA. Nutrients 9, 1305.
126. Bhatt, DL, Steg, PG, Miller, M, et al. (2019) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380, 11–22.
127. Manson, JE, Cook, NR, Lee, IM, et al. (2019) Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med 380, 23–32.
128. Brenna, JT, Plourde, M, Stark, KD, et al. (2018) Best practices for the design, laboratory analysis, and reporting of trials involving fatty acids. Am J Clin Nutr 108, 211–227.
129. Browning, LM, Walker, CG, Mander, AP, et al. (2012) Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 96, 748–758.